MC1795A1 - Derives de banzazecine - Google Patents
Derives de banzazecineInfo
- Publication number
- MC1795A1 MC1795A1 MC871868A MC1868A MC1795A1 MC 1795 A1 MC1795 A1 MC 1795A1 MC 871868 A MC871868 A MC 871868A MC 1868 A MC1868 A MC 1868A MC 1795 A1 MC1795 A1 MC 1795A1
- Authority
- MC
- Monaco
- Prior art keywords
- chloro
- cpds
- acetyl
- banzazecin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D227/00—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
- C07D227/02—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D227/06—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D227/08—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH26686 | 1986-01-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
MC1795A1 true MC1795A1 (fr) | 1987-10-22 |
Family
ID=4183090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MC871868A MC1795A1 (fr) | 1986-01-23 | 1987-01-22 | Derives de banzazecine |
Country Status (30)
Country | Link |
---|---|
US (4) | US4732979A (fr) |
EP (1) | EP0230967B1 (fr) |
JP (1) | JPS62169770A (fr) |
KR (1) | KR910000659B1 (fr) |
CN (1) | CN1013111B (fr) |
AT (1) | ATE68790T1 (fr) |
AU (1) | AU590042B2 (fr) |
CS (1) | CS258147B2 (fr) |
DD (1) | DD264431A5 (fr) |
DE (1) | DE3773950D1 (fr) |
DK (1) | DK35887A (fr) |
FI (1) | FI82931C (fr) |
GB (1) | GB2185744B (fr) |
HU (1) | HU197883B (fr) |
IE (1) | IE870167L (fr) |
IL (1) | IL81317A (fr) |
IS (1) | IS3190A7 (fr) |
MC (1) | MC1795A1 (fr) |
MT (1) | MTP996B (fr) |
MW (1) | MW187A1 (fr) |
NO (1) | NO167385C (fr) |
NZ (1) | NZ218987A (fr) |
OA (1) | OA08469A (fr) |
PH (1) | PH22879A (fr) |
PL (1) | PL263796A1 (fr) |
PT (1) | PT84181B (fr) |
TN (1) | TNSN87006A1 (fr) |
YU (1) | YU7087A (fr) |
ZA (1) | ZA87407B (fr) |
ZW (1) | ZW1087A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3773950D1 (de) * | 1986-01-23 | 1991-11-28 | Hoffmann La Roche | Benzazecin-derivate. |
IN167395B (fr) * | 1987-07-21 | 1990-10-20 | Hoffmann La Roche | |
EP0591582B1 (fr) * | 1991-08-21 | 1999-01-20 | Eli Lilly And Company | Hexahydrobenzo(f)quinolinones comme inhibiteurs de 5-alpha-réductase |
US5250539A (en) * | 1991-08-21 | 1993-10-05 | Eli Lilly And Company | Hexahydrobenzo[f]quinolinones |
EP0591583B1 (fr) * | 1991-08-21 | 2001-12-19 | Eli Lilly And Company | Benzo(f)quinolinones comme inhibiteurs du 5-alpha-réducase |
US5239075A (en) * | 1991-08-21 | 1993-08-24 | Eli Lilly And Company | Process for the preparation of benzo (f) quinolinones |
WO1994022444A1 (fr) * | 1993-03-29 | 1994-10-13 | Smithkline Beecham Corporation | Composes tricycliques utilises pour inhiber l'agregation plaquettaire |
GB9317314D0 (en) * | 1993-08-20 | 1993-10-06 | Smithkline Beecham Corp | Compounds |
KR970706271A (ko) | 1994-09-20 | 1997-11-03 | 스티븐슨 린다 에스. | 시냅스 전달 향상용 약제(drugs to improve synaptic transmission) |
US20050067341A1 (en) * | 2003-09-25 | 2005-03-31 | Green Dennis H. | Continuous production membrane water treatment plant and method for operating same |
US7094331B2 (en) * | 2003-11-05 | 2006-08-22 | Marathon Ashland Petroleum Llc | Viscosity modification of heavy hydrocarbons using dihydric alcohols |
US20090263439A1 (en) * | 2008-04-18 | 2009-10-22 | The Procter & Gamble Company | Antimicrobial Preservative Free Wipe |
CN106117028B (zh) * | 2016-06-14 | 2019-01-01 | 浙江永太药业有限公司 | 一种制备卤代-3,4-二氢-1h-2-萘酮的工艺方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE442586A (fr) * | 1940-07-31 | |||
JPS5129710B2 (fr) * | 1972-09-09 | 1976-08-27 | ||
US4341786A (en) * | 1981-03-02 | 1982-07-27 | Smithkline Corporation | Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds |
US4521423A (en) * | 1983-10-31 | 1985-06-04 | Ayerst, Mckenna & Harrison, Ltd. | 7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them |
DE3773950D1 (de) * | 1986-01-23 | 1991-11-28 | Hoffmann La Roche | Benzazecin-derivate. |
-
1987
- 1987-01-20 DE DE8787100733T patent/DE3773950D1/de not_active Expired - Lifetime
- 1987-01-20 MW MW1/87A patent/MW187A1/xx unknown
- 1987-01-20 EP EP87100733A patent/EP0230967B1/fr not_active Expired - Lifetime
- 1987-01-20 YU YU00070/87A patent/YU7087A/xx unknown
- 1987-01-20 PH PH34744A patent/PH22879A/en unknown
- 1987-01-20 CS CS87418A patent/CS258147B2/cs unknown
- 1987-01-20 FI FI870220A patent/FI82931C/fi not_active IP Right Cessation
- 1987-01-20 IL IL81317A patent/IL81317A/xx unknown
- 1987-01-20 AT AT87100733T patent/ATE68790T1/de not_active IP Right Cessation
- 1987-01-20 ZA ZA87407A patent/ZA87407B/xx unknown
- 1987-01-20 NZ NZ218987A patent/NZ218987A/en unknown
- 1987-01-21 US US07/005,712 patent/US4732979A/en not_active Expired - Fee Related
- 1987-01-21 ZW ZW10/87A patent/ZW1087A1/xx unknown
- 1987-01-21 HU HU87163A patent/HU197883B/hu not_active IP Right Cessation
- 1987-01-21 DD DD87299380A patent/DD264431A5/de unknown
- 1987-01-22 AU AU67911/87A patent/AU590042B2/en not_active Ceased
- 1987-01-22 TN TNTNSN87006A patent/TNSN87006A1/fr unknown
- 1987-01-22 DK DK035887A patent/DK35887A/da not_active Application Discontinuation
- 1987-01-22 CN CN87100312A patent/CN1013111B/zh not_active Expired
- 1987-01-22 MC MC871868A patent/MC1795A1/fr unknown
- 1987-01-22 JP JP62011477A patent/JPS62169770A/ja active Pending
- 1987-01-22 GB GB8701416A patent/GB2185744B/en not_active Expired
- 1987-01-22 NO NO870280A patent/NO167385C/no unknown
- 1987-01-22 IS IS3190A patent/IS3190A7/is unknown
- 1987-01-22 PT PT84181A patent/PT84181B/pt not_active IP Right Cessation
- 1987-01-22 IE IE870167A patent/IE870167L/xx unknown
- 1987-01-22 MT MT996A patent/MTP996B/xx unknown
- 1987-01-23 OA OA59052A patent/OA08469A/fr unknown
- 1987-01-23 PL PL1987263796A patent/PL263796A1/xx unknown
- 1987-01-23 KR KR1019870000533A patent/KR910000659B1/ko not_active IP Right Cessation
- 1987-11-18 US US07/121,987 patent/US4749791A/en not_active Expired - Fee Related
-
1988
- 1988-02-11 US US07/154,760 patent/US4876340A/en not_active Expired - Fee Related
-
1989
- 1989-08-17 US US07/395,380 patent/US4957911A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MC1795A1 (fr) | Derives de banzazecine | |
GR1000307B (el) | Μεθοδος παρασκευης παραγωγων αδενοσινης. | |
DE3887014D1 (de) | Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen. | |
LU88790I2 (fr) | Moxidectin et ses dérivés pharmaceutiquement acceptables | |
NO885210D0 (no) | Anvendelse av cellulosederivater i borspylinger. | |
FI892675A0 (fi) | 2,6-dihalogenpyridin-3 -karboxylsyraderivat och deras framstaellning. | |
FI884345A0 (fi) | Sackaridderivat. | |
NO911798D0 (no) | 3'-deamino-4'-deoksy-4'-amino-8-fluorantracykliner og deres fremstilling. | |
ES2073919T3 (es) | Derivados de piperidina 1,3,4-trisubstituidos, su obtencion y empleo. | |
GR880100196A (el) | Υποκατεστημενα 1,3-διοξολαν-και 1,3-διοξαν-παραγωγα,μεθοδοι για την παρασκευη τους και η χρηση τους | |
NO930016D0 (no) | Derivater av hypofysens baklapphormoner | |
GR1000138B (el) | Νεα παραγωγα ριβοφουρανουρονικου οξεος, μεθοδος δια την παρασευη αυτων και η χρησιμοποιησις αυτων. | |
RO96381A2 (fr) | Procede pour la synthese d'azobiscyclopentancarbonitryle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
YP | Annual fee paid |